Market Tracker

10/16 5:16pm ET

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

10.68
Delayed Data
As of Oct 16
 -0.1099 / -1.02%
Today’s Change
5.70
Today|||52-Week Range
11.34
+74.51%
Year-to-Date
No recent news for Oramed Pharmaceuticals Inc.

Today’s Trading

Previous close10.79
Today’s open10.49
Day’s range10.30 - 10.79
Volume81,811
Average volume (3 months)58,400
Market cap$143.7M
Dividend yield--
Data as of 3:59pm ET, 10/16/2017

Growth & Valuation

Earnings growth (last year)-29.85%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales142.00
Price/Book5.43

Competitors

 Today’s
change
Today’s
% change
AGRXAgile Therapeutics I...-0.16-3.19%
MTNBMatinas BioPharma Ho...-0.04-3.15%
--EcoGreen Internation...0.000.00%
CPIXCumberland Pharmaceu...+0.17+2.41%
Data as of 6:29pm ET, 10/16/2017

Financials

Next reporting dateNovember 1, 2017
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$641.0K
Annual profit (last year)-$11.0M
Net profit margin-1,710.45%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, Jerusalem

Forecasts